Get startedLog in
    Picture of Ambrx Biopharma logo

    AMAM — Ambrx Biopharma News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapHigh Flyer
    All News

    Johnson & Johnson to buy Ambrx Biopharma for $2 bln

    Picture of Ambrx Biopharma logoAmbrx Biopharma
    08/01/2024 12:33
    Jan 8 (Reuters) - Johnson & Johnson  JNJ.N  said on
Monday it had agreed to buy drug developer Ambrx Biopharma
 AMAM.O  for $2 billion to gain access to its portfolio of
targeted cancer therapies. 

 (Reporting by Manas Mishra in Bengaluru; Editing by Krishna
Chandra Eluri)
 ((Manas.Mishra@thomsonreuters.com;
www.twitter.com/Manaswrites15;))

    Recent news on Ambrx Biopharma

    See all news